Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Gastric Cancer

  Free Subscription


19.01.2026

2 BMC Cancer
1 BMC Surg
1 Br J Cancer
1 Cancer Lett
2 Cancer Res
1 Clin Cancer Res
1 Int J Oncol
2 Lancet
1 Mol Ther Oncol
1 Oncol Rep
1 Oncology
2 Surgery


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. LIN X, Shi W, Zhou Z, Li D, et al
    Molecular features of early- vs. late-onset gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15567.
    PubMed         Abstract available

  2. AKELLO VV, Ocan M, Kinengyere AA
    Histopathological subtypes and topographical subsites of gastric cancer in Sub-Saharan Africa: a scoping review.
    BMC Cancer. 2026 Jan 13. doi: 10.1186/s12885-026-15560.
    PubMed         Abstract available


    BMC Surg

  3. LIU W, He L, Yin C, Gong G, et al
    Enhanced recovery after gastrectomy: updated Meta-analysis of 27 randomized trials (2018-2025).
    BMC Surg. 2025;26:26.
    PubMed         Abstract available


    Br J Cancer

  4. SHI DB, Qin YC, Liu S, Zhao RN, et al
    INHBA, regulated by C/EBPbeta, induces M2 macrophage polarization to promote tumor metastasis and growth via activating the PI3K/AKT pathway in gastric cancer.
    Br J Cancer. 2026 Jan 15. doi: 10.1038/s41416-025-03326.
    PubMed         Abstract available


    Cancer Lett

  5. ZHANG J, Wang J, Guo Q, Wang Y, et al
    Corrigendum to "LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells" [Cancer Lett. 317 (2012) 24-32].
    Cancer Lett. 2026 Jan 12:218250. doi: 10.1016/j.canlet.2026.218250.
    PubMed        


    Cancer Res

  6. LIU X, Chen B, Xie F, Wong KY, et al
    Correction: FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis.
    Cancer Res. 2026;86:556.
    PubMed        

  7. LIAO F, Tong Y, Sun H, Chen S, et al
    Nerves Stimulates Crosstalk between Gastric Cancer and Group 3 Innate Lymphoid Cells to Enhance Immunosuppression.
    Cancer Res. 2026 Jan 14. doi: 10.1158/0008-5472.CAN-25-3092.
    PubMed         Abstract available


    Clin Cancer Res

  8. LEE KW, Bai LY, Jung M, Ying J, et al
    Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma.
    Clin Cancer Res. 2026;32:312-323.
    PubMed         Abstract available


    Int J Oncol

  9. WANG J, Liang WJ, Min GT, Wang HP, et al

    [Retracted] LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer

    .
    Int J Oncol. 2026;68:34.
    PubMed         Abstract available


    Lancet

  10. LIU C, Peng Z, Qi C, Shen L, et al
    Rethinking CLDN18.2 expression in gastric cancer therapy - Authors' reply.
    Lancet. 2026;407:130.
    PubMed        

  11. LUO P, Wong HZH, Shan D
    Rethinking CLDN18.2 expression in gastric cancer therapy.
    Lancet. 2026;407:129-130.
    PubMed        


    Mol Ther Oncol

  12. SEO MJ, Jeong JH, Park HN, Baek IP, et al
    Novel syngeneic model of anti-mouse CLDN18.2 CAR -T therapy for gastric cancer demonstrates a synergy with TGF-beta and PD-L1 inhibitors.
    Mol Ther Oncol. 2025;34:201120.
    PubMed         Abstract available


    Oncol Rep

  13. CONG N, Du P, Zhang A, Shen F, et al

    [Retracted] Downregulated microRNA?200a promotes EMT and tumor growth through the Wnt/beta?catenin pathway by targeting the E?cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma

    .
    Oncol Rep. 2026;55:40.
    PubMed         Abstract available


    Oncology

  14. KIMURA A, Sano A, Nakazawa N, Kumakura Y, et al
    Multicenter Study on the Safety and Efficacy of First-Line Nivolumab-Combination Chemotherapy in Patients Aged 75 years and Older with Unresectable Advanced or Recurrent Gastric Cancer.
    Oncology. 2026 Jan 12:1-17. doi: 10.1159/000550345.
    PubMed         Abstract available


    Surgery

  15. POMORTSEV B, Dalgatov K, Sinyakhin S, Baziyan Y, et al
    Modified Billroth I versus Roux-en-Y reconstruction after laparoscopic distal gastrectomy: Propensity-matched analysis of perioperative, pathologic, and quality-of-life outcomes in a European cohort.
    Surgery. 2026;190:109825.
    PubMed         Abstract available

  16. LEE DG, Kim J, Lee JH
    Extended follow-up after gastrectomy in elderly patients: Improved postrecurrence survival but no overall survival benefit in patients aged 73 years or older.
    Surgery. 2026;190:109821.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.